| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | enzyme activator activity | 2.06e-04 | 656 | 50 | 8 | GO:0008047 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 3.99e-04 | 12 | 50 | 2 | GO:0004706 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 6.28e-04 | 775 | 50 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 9.85e-04 | 78 | 50 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.05e-03 | 839 | 50 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.06e-03 | 840 | 50 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.06e-03 | 840 | 50 | 8 | GO:0016818 | |
| GeneOntologyBiologicalProcess | lateral mesoderm morphogenesis | 1.34e-07 | 5 | 50 | 3 | GO:0048369 | |
| GeneOntologyBiologicalProcess | lateral mesoderm formation | 1.34e-07 | 5 | 50 | 3 | GO:0048370 | |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 1.48e-05 | 20 | 50 | 3 | GO:0048368 | |
| GeneOntologyBiologicalProcess | lateral mesodermal cell differentiation | 3.44e-05 | 4 | 50 | 2 | GO:0048371 | |
| Domain | MAP3K12_MAP3K13 | 7.31e-06 | 2 | 51 | 2 | IPR017419 | |
| Domain | AT_hook | 2.46e-03 | 27 | 51 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.46e-03 | 27 | 51 | 2 | IPR017956 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | IPR000330 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | PF00176 | |
| Domain | - | 3.95e-03 | 746 | 51 | 7 | 3.40.50.300 | |
| Domain | BROMODOMAIN_1 | 4.58e-03 | 37 | 51 | 2 | PS00633 | |
| Domain | Bromodomain | 4.83e-03 | 38 | 51 | 2 | PF00439 | |
| Domain | Pkinase_Tyr | 5.26e-03 | 129 | 51 | 3 | PF07714 | |
| Domain | BROMODOMAIN_2 | 5.60e-03 | 41 | 51 | 2 | PS50014 | |
| Domain | BROMO | 5.87e-03 | 42 | 51 | 2 | SM00297 | |
| Domain | Bromodomain | 5.87e-03 | 42 | 51 | 2 | IPR001487 | |
| Domain | - | 5.87e-03 | 42 | 51 | 2 | 1.20.920.10 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.34e-03 | 138 | 51 | 3 | IPR001245 | |
| Domain | P-loop_NTPase | 7.87e-03 | 848 | 51 | 7 | IPR027417 | |
| Pubmed | CYLC1 PHEX BMPR1A ERCC5 MAP1B CBX5 ASH1L NAV2 BOD1L1 APOB FNBP1L RAD54L2 RAB3B | 1.42e-07 | 1442 | 52 | 13 | 35575683 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 9353328 | ||
| Pubmed | Leucine Zipper-bearing Kinase promotes axon growth in mammalian central nervous system neurons. | 2.19e-06 | 2 | 52 | 2 | 27511108 | |
| Pubmed | Impaired regenerative response of primary sensory neurons in ZPK/DLK gene-trap mice. | 2.19e-06 | 2 | 52 | 2 | 19358824 | |
| Pubmed | Regulator of G-protein signaling 2 (RGS2) suppresses premature calcium release in mouse eggs. | 6.57e-06 | 3 | 52 | 2 | 26160904 | |
| Pubmed | A Critical Role for DLK and LZK in Axonal Repair in the Mammalian Spinal Cord. | 6.57e-06 | 3 | 52 | 2 | 35361703 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 33475086 | ||
| Pubmed | 2.96e-05 | 1084 | 52 | 9 | 11544199 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.33e-05 | 410 | 52 | 6 | 26949251 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP1B NFIC TRPS1 ASH1L OS9 BOD1L1 BTAF1 FNBP1L HSD11B2 MAP3K12 | 6.14e-05 | 1489 | 52 | 10 | 28611215 |
| Pubmed | 9.64e-05 | 497 | 52 | 6 | 23414517 | ||
| Pubmed | 1.27e-04 | 326 | 52 | 5 | 17015433 | ||
| Pubmed | 1.35e-04 | 529 | 52 | 6 | 14621295 | ||
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 28641113 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.57e-04 | 341 | 52 | 5 | 32971831 | |
| Pubmed | The environmental and genetic evidence for the association of hyperlipidemia and hypertension. | 1.69e-04 | 13 | 52 | 2 | 19155782 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.01e-04 | 569 | 52 | 6 | 30639242 | |
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 2.27e-04 | 15 | 52 | 2 | 18855897 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.29e-04 | 583 | 52 | 6 | 29844126 | |
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 8764009 | ||
| Pubmed | Direct interaction of human TFIID with the HIV-1 transactivator tat. | 2.60e-04 | 16 | 52 | 2 | 8121496 | |
| Pubmed | Identification of FGF10 targets in the embryonic lung epithelium during bud morphogenesis. | 2.60e-04 | 16 | 52 | 2 | 15556938 | |
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 8680883 | ||
| Pubmed | A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. | 2.60e-04 | 16 | 52 | 2 | 7836461 | |
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 7835343 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 2.74e-04 | 857 | 52 | 7 | 25609649 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.86e-04 | 608 | 52 | 6 | 36089195 | |
| Pubmed | Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development. | 2.94e-04 | 17 | 52 | 2 | 19398581 | |
| Pubmed | 3.05e-04 | 215 | 52 | 4 | 35973513 | ||
| Pubmed | Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. | 3.30e-04 | 18 | 52 | 2 | 7933101 | |
| Pubmed | 3.62e-04 | 225 | 52 | 4 | 12168954 | ||
| Pubmed | 3.69e-04 | 19 | 52 | 2 | 8764062 | ||
| Pubmed | Isl1Cre reveals a common Bmp pathway in heart and limb development. | 3.69e-04 | 19 | 52 | 2 | 16556916 | |
| Pubmed | Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. | 4.09e-04 | 20 | 52 | 2 | 17884155 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 4.13e-04 | 233 | 52 | 4 | 32290105 | |
| Pubmed | 4.34e-04 | 98 | 52 | 3 | 16783635 | ||
| Pubmed | Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. | 5.44e-04 | 23 | 52 | 2 | 16314491 | |
| Pubmed | 5.76e-04 | 453 | 52 | 5 | 29656893 | ||
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 32212159 | ||
| Pubmed | 6.40e-04 | 1297 | 52 | 8 | 33545068 | ||
| Pubmed | A single-cell time-lapse of mouse prenatal development from gastrula to birth. | 6.43e-04 | 25 | 52 | 2 | 38355799 | |
| Pubmed | 7.48e-04 | 1014 | 52 | 7 | 32416067 | ||
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 16966370 | ||
| Pubmed | 8.67e-04 | 29 | 52 | 2 | 20167577 | ||
| Pubmed | Isolation and characterization of proteins associated with histone H3 tails in vivo. | 9.29e-04 | 30 | 52 | 2 | 17403666 | |
| Pubmed | The tissue-specific transcriptomic landscape of the mid-gestational mouse embryo. | 9.29e-04 | 30 | 52 | 2 | 24803591 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.02e-03 | 774 | 52 | 6 | 15302935 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.19e-03 | 533 | 52 | 5 | 30554943 | |
| Pubmed | 1.22e-03 | 140 | 52 | 3 | 16778019 | ||
| Pubmed | 1.27e-03 | 808 | 52 | 6 | 20412781 | ||
| Pubmed | 1.30e-03 | 1116 | 52 | 7 | 31753913 | ||
| Pubmed | 1.41e-03 | 37 | 52 | 2 | 35974052 | ||
| Pubmed | Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences. | 1.49e-03 | 38 | 52 | 2 | 10501973 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.23e-04 | 24 | 34 | 2 | 654 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-06 | 190 | 52 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-06 | 199 | 52 | 5 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-06 | 200 | 52 | 5 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 2.67e-06 | 180 | 50 | 6 | 6939_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.95e-05 | 174 | 50 | 5 | 7179_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.28e-05 | 177 | 50 | 5 | 4954_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.89e-05 | 182 | 50 | 5 | 6879_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 5.29e-05 | 185 | 50 | 5 | 6916_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.85e-05 | 189 | 50 | 5 | 836_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.00e-05 | 190 | 50 | 5 | 3966_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 6.00e-05 | 190 | 50 | 5 | 6769_DN | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 6.46e-05 | 193 | 50 | 5 | 950_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.78e-05 | 195 | 50 | 5 | 6834_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.78e-05 | 195 | 50 | 5 | 1045_UP | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 6.95e-05 | 196 | 50 | 5 | 7329_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.95e-05 | 196 | 50 | 5 | 6057_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; HL60; HG-U133A | 7.12e-05 | 197 | 50 | 5 | 2011_DN | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 6596_UP | |
| Drug | clotrimazole; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 7.29e-05 | 198 | 50 | 5 | 905_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; PC3; HG-U133A | 7.29e-05 | 198 | 50 | 5 | 1938_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; HL60; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 2159_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 7.47e-05 | 199 | 50 | 5 | 3223_DN | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HG-U133A | 7.47e-05 | 199 | 50 | 5 | 447_UP | |
| Disease | triglyceride change measurement, intermediate density lipoprotein measurement | 1.55e-05 | 4 | 48 | 2 | EFO_0007681, EFO_0008595 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.23e-04 | 59 | 48 | 3 | EFO_0009658, GO_0009410 | |
| Disease | amenorrhea, response to antineoplastic agent | 2.68e-04 | 15 | 48 | 2 | EFO_0010269, GO_0097327 | |
| Disease | aggressive behavior | 7.59e-04 | 25 | 48 | 2 | EFO_0003015 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 1.02e-03 | 121 | 48 | 3 | EFO_0004612, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGSGFGKKSKDMSTE | 151 | Q99814 | |
| DFKMGGASDVSTAKS | 531 | Q9NR48 | |
| MGKKTKRTADSSSSE | 1 | P45973 | |
| KLATEGSSGATEKMK | 61 | Q9NW68 | |
| GSSGATEKMKKGLSD | 66 | Q9NW68 | |
| MDSKKRSSTEAEGSK | 1 | Q96Q42 | |
| KKAMESSSNSDSDSG | 236 | Q9UIF8 | |
| IKKAGSDGDIMDSST | 1241 | Q6F5E8 | |
| FKTSATKGTGLDEAM | 156 | P40616 | |
| GTKGKGEDSTLASSM | 661 | Q9Y4B4 | |
| DSGFGKETAKKLDSM | 91 | P80365 | |
| ISSKGDEGEKKSTFM | 481 | Q9UPW5 | |
| MASVTDGKTGVKDAS | 1 | P20337 | |
| DGGKSKRSTVDSKAM | 176 | Q5VW38 | |
| MSTALGSTENTGKEK | 1796 | Q8WXI7 | |
| GSFKEDTKMSISEGT | 1511 | P46821 | |
| EYEKTKGKAMGTADS | 586 | Q86VF7 | |
| KKIDESDGTSANSKM | 556 | P35663 | |
| KSKADKMKEGSDSSV | 491 | Q8TC05 | |
| KMKEGSDSSVSSEKG | 496 | Q8TC05 | |
| SMGKTSGKLFDSSDD | 826 | Q76FK4 | |
| SKELSDKSTKMSFAG | 301 | O43283 | |
| TTTMHSEAKKGSKFD | 151 | Q8N131 | |
| VDSMSGTEKGSKDTD | 1931 | Q8NFC6 | |
| EGTKKMGLAFESTKS | 301 | P04114 | |
| DGTISASKQESGKMD | 296 | Q5T0N5 | |
| AEKADTSTSGKASMK | 1806 | O14981 | |
| KGGSVDITKESMKEG | 2771 | Q8N3K9 | |
| HGTGMKSDSDQKKSE | 31 | P36894 | |
| AGKTSTFKMLTGDES | 2091 | Q9BZC7 | |
| GTSKELSDKSTKMSF | 256 | Q12852 | |
| MAGSDFIKTSTGKET | 211 | Q9Y315 | |
| MDKSAGSGHKSEEKR | 16 | P41220 | |
| MKGTASGSSRSKSKD | 176 | Q12962 | |
| IMKVKSDGSHSKGDG | 66 | A0A075B6K6 | |
| TGKESSKSMTVKVSG | 401 | Q9UQ74 | |
| SSSSDSDDDGGKEKM | 1146 | P28715 | |
| DVKKSDGGSDSGIKM | 1011 | Q8IVL1 | |
| MSSSLGKEKDSKEKD | 1 | Q9UQ13 | |
| KSASSKGEGFDVMKS | 46 | P55039 | |
| SSGSKRHKSGSMEED | 276 | P08651 | |
| MAGASPTKDDSKDSD | 296 | Q13438 | |
| EGETMTKTDKSSSGA | 491 | Q9UHF7 | |
| SGKEKGSDSFKSEKM | 1536 | Q8NI27 | |
| GSDSFKSEKMDKISS | 1541 | Q8NI27 | |
| SMSTGEGSKEAQKVK | 646 | Q5VU36 | |
| RKGDESMTKASDSSS | 446 | Q92610 | |
| GTKMFVSESKETASG | 321 | O75695 | |
| MEAETGSSVETGKKA | 1 | P78562 | |
| SERKGKSEMQGGSKT | 76 | Q9H3H9 | |
| KKSSMDEGTAGSEAM | 521 | Q9NQ66 | |
| AALMSSGGSKEKEAT | 21 | Q9UMR3 | |
| MDTKGHKTAGDVGSK | 701 | Q05996 | |
| KKEEESAGGTKGSSK | 11 | P61081 | |
| SSEEDCKKKKGSMSD | 166 | Q15049 |